Patent prosecution的問題，透過圖書和論文來找解法和答案更準確安心。 我們找到下列問答集和資訊懶人包

European SPCs Unravelled: A Practitioner’s Guide to Supplementary Protection Certificates in Europe

為了解決Patent prosecution的問題，作者Von Uexküll, Alexa (EDT)/ Ridderbusch, Oswin (EDT) 這樣論述：

About this book: European SPCs Unravelled provides an easily accessible overview of SPC law in Europe through a practice-oriented approach. While SPCs are governed by the same substantive rules in all Member States of the European Union and the European Economic Area, they are national IP rights. Th

e formal requirements and procedural practices of the national patent offices granting SPCs still differ significantly, and these divergences can have a substantial impact in the prosecution of SPCs across Europe. This book covers all substantive and procedural aspects of prosecution, enforcement, a

nd invalidation, as well as SPC-related aspects of unfair competition law across European jurisdictions.What's in this book: Following an overarching European chapter, which addresses general considerations and the relevant European Union law, including the jurisprudence of the Court of Justice (CJ

EU) and the EFTA Court, this book contains separate national chapters for eleven key jurisdictions - i.e., Germany, the United Kingdom, France, the Netherlands, Belgium, Italy, Spain, Portugal, Sweden, Iceland, and Switzerland, as well as a concluding chapter summarizing the fundamentals of SPC law

and practice in sixteen further European countries. The contributors to this book, all experts in the field of SPCs in their respective jurisdictions, provide clear and hands-on guidance on a range of specific topics of practical and strategic relevance, including: What is or is not an 'active ingre

dient' amenable to SPC protection?What is required for an active ingredient to be 'protected' by a basic patent?What relevance has the 'core inventive advance' of the basic patent?Can SPCs be obtained for 'loose' combinations of separately formulated active ingredients?Which basic patent should be c

hosen for an SPC filing?Which types of marketing authorizations can be relied upon?Under which conditions can SPCs be obtained for a new specific salt, ester, or other derivative of a previously approved active ingredient, for a new specific enantiomer of a previously approved racemate, and for new

therapeutic applications of previously approved active ingredients?Can affiliated companies obtain several SPCs for the same product?Does the revocation of an SPC enable the filing of a new SPC for the same product?What are the limits to the filing of 'unfriendly' SPCs based on third-party marketing

authorizations?What relevance does the product definition of an SPC have for its scope of protection?What is the scope of protection of an SPC in relation to derivatives of an active ingredient?How is the SPC term calculated, and how can an erroneous term be corrected?How can SPCs and paediatric ex

tensions be invalidated and which grounds of invalidity can be invoked?What pitfalls must be avoided in terms of unfair competition law?How this will help you: As the chapters are structured from the perspective of practitioners, this book provides answers to the frequently raised problems concerni

ng SPCs. This approach distinguishes this book from other commentaries and thereby serves as invaluable assistance to IP practitioners in devising successful pan-European SPC filing strategies. Its country-by-country format makes it easy to compare the national practices and the respective national

case law of the different European countries.

The Practitioner’s Guide to Trials Before the Patent Trial and Appeal Board

為了解決Patent prosecution的問題，作者Arner, Erika Harmon (EDT)/ Daley, Kathleen A. (EDT)/ Flibbert, M 這樣論述：

Trials before the Patent Trial and Appeal Board (PTAB), introduced to U.S. patent law by the Leahy-Smith America Invents Act, are a hybrid of conventional patent prosecution and patent litigation practices. Successfully navigating a PTAB trial may entail tasks ranging from analyzing highly technical

prior art to deposing scientific experts, drafting patent-claim amendments, and arguing at an oral hearing before an expert panel. Now updated and significantly expanded, the new Second Edition of The Practitioner's Guide to Trials Before the Patent Trial and Appeal Board is a concise resource for

practitioners actively involved in managing the unique aspects of PTAB trials. Having handled dozens of PTAB proceedings, the lead authors share their practical experience in this developing area and provide a unique perspective for practitioners advising clients and planning strategy during PTAB tr

ials. Organized for ease of use, the book's practice-focused information includes: - A quick reference for PTAB statutes and rules- Building patent trials into your litigation strategy- A detailed description of a PTAB trial from petition preparation to appeals to the Court of Appeals for the Federa

l Circuit- Clear references to supporting laws, rules, and regulations The "Practical Tools" chapter compiles, in one place, the statutes, rules, and PTAB guidance covering PTAB trials, organized by topic. These are organized using a simple, standard framework including CFR citations; PTO comments d

uring rulemaking; PTAB orders and decisions; references to the PTAB trial practice guide; and informal guidance such as PTAB training presentations. The book also provides an online site with relevant documents that can be quickly downloaded. Erika Harmon Arner is a partner at Finnegan, Henderson,

Farabow, Garrett & Dunner, LLP, in Reston, Virginia, where she has represented both patent owners and petitioners in over 100 trials--most as lead counsel--before the Patent Trial and Appeal Board (PTAB). Kathleen A. Daley is a partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, in Wash

ington, D.C., where she has extensive experience in litigation before district courts, the USITC, the PTAB, and the U.S. Court of Appeals for the Federal Circuit. Michael J. Flibbert is a partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP in Washington, D.C., and has than 20 years of pat

ent litigation experience.

標準必要專利之研究－以FRAND授權承諾為中心

為了解決Patent prosecution的問題，作者劉舒容 這樣論述：

中文摘要近年來標準必要專利訴訟，例如Microsoft v. Motorola案、Huawei v. ZTE案、Qualcomm案等，乃國際間所關注之焦點。而各國之行政與司法部門所為之裁決，莫不影響著企業之專利布局與技術領先地位，以及全球經濟與產業之發展。然而，探究該等訴訟之內容，除了案件複雜性甚高之外，其中更涉及鉅額權利金之判斷，禁制令核發之標準，以及企業對自由競爭市場之影響。本文將以標準必要專利為主題，依序探討標準與專利結合之原因、標準必要專利所挾帶之風險、標準制定組織如何預防採行標準必要專利所產生之問題、專利權人於接受標準制定組織之智慧財產政策後，其所為的F/RAND授權承諾性質為何、

權利金又是如何計算。此外，在標準必要專利權人負有授權義務的情況下，專利權人是否尚得行使專利排他權而請求禁制令、各國對於標準必要專利案件之禁制令核發門檻有無不同、以及標準必要專利與競爭法之關連。